secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCW Biologics Inc. (HCWB)
CIK:        0001828673
Form:       8-K
Filed at:   2026-02-19T23:59:59+00:00
Accession:  0001193125-26-059578
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud

HCW Biologics prices $1.5M follow-on offering and seeks to reprice existing warrants
--------------------------------------------------------------------------------

- Entered securities purchase agreement for follow-on offering of 2,477,292 units at $0.6055 per unit.
- Gross proceeds of approximately $1.5 million before fees and expenses.
- Common warrants have exercise price of $0.6055 per share, subject to shareholder approval, expire in 5 years.
- Agreed to seek shareholder approval to reduce exercise price of existing warrants from $2.41 to $0.6055 per share.
- Placement agent Maxim Group LLC will receive a cash fee equal to 6.9% of gross proceeds.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828673/000119312526059578/0001193125-26-059578-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828673/000119312526059578/hcwb-20260217.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-059578

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer